Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorChang, Dwayne T Sen
dc.contributor.authorLawrentschuk, Nathanen
dc.identifier.citationUrology Annals; 7(1): 1-7en
dc.description.abstractOrthotopic neobladder reconstruction is becoming an increasingly common urinary diversion following cystectomy for bladder cancer. This is in recognition of the potential benefits of neobladder surgery over creation of an ileal conduit related to quality of life (QoL), such as avoiding the need to form a stoma with its cosmetic, psychological and other potential complications. The PubMed database was searched using relevant search terms for articles published electronically between January 1994 and April 2014. Full-text articles in English or with English translation were assessed for relevance to the topic before being included in the review. Patients with neobladders have comparable or better post-operative sexual function than those with ileal conduits. They also have comparable QoL to those with ileal conduits. Orthotopic neobladder is a good alternative to ileal conduit in suitable patients who do not want a stoma and are motivated to comply with neobladder training. However, the selection of a neobladder as the urinary diversion of choice requires that patients have good renal and liver functions and are likely to be compliant with neobladder training. With benefits also come potential risks of neobladder formation. These include electrolyte abnormalities and nocturnal incontinence. This short review highlights current aspects of neobladder formation and its potential advantages.en
dc.subject.otherErectile dysfunctionen
dc.subject.otherquality of lifeen
dc.subject.otherurinary bladderen
dc.subject.otherurinary diversionen
dc.subject.otherurinary incontinenceen
dc.titleOrthotopic neobladder reconstruction.en
dc.typeJournal Articleen
dc.identifier.journaltitleUrology annalsen
dc.identifier.affiliationDepartment of Surgery, University of Melbourne, Victoria ; Ludwig Institute for Cancer Research, Austin Hospital, Melbourne, Victoria ; Department of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australiaen
dc.identifier.affiliationDepartment of Urology, Fremantle Hospital and Health Service, Fremantle, Western Australiaen
dc.type.austinJournal Articleen
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

checked on Mar 1, 2024

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.